Abstract:The transmission of parasites into the vertebrate host skin begins with the inoculation of a few sporozoites during the bite of an infected mosquito. This motile stage invades cutaneous blood vessels to reach the liver and infect hepatocytes. The first approved malaria vaccine RTS, S/AS01 elicits high titers of antibodies against the circumsporozoite protein (CSP), the main protein on the surface of sporozoites. Protection mainly unfolds during parasite migration through the host, but rare and potent protective antibodies can additionally neutralize sporozoite in the blood and liver. Here, using microscopy and bioluminescence imaging in a rodent malaria model, we show the dynamics of parasite elimination in the liver by the 3D11 anti-CSP monoclonal antibody (mAb) targeting the repetitive region of the CSP. Our data confirmed that in passively immunized mice protection against an intravenous sporozoite challenge requires much higher concentrations of antibody than a cutaneous challenge adjusted to elicit the same level of infection. Sporozoite arrest in the liver was not affected by the protective antibody. A two-fold decrease in the crossing of the hepatic sinusoidal barrier was observed after three hours post sporozoite inoculation, associated with the loss of parasite motility. Intriguingly, the elimination of most parasites in the liver occurred after 5 hours post-inoculation, indicating a late action of this protective antibody. , 3D11 strongly inhibited the invasion of HepG2 cells by sporozoites in positive correlation with its cytotoxic activity. Additionally, this protective mAb impaired the intracellular development of liver stages, confirming the late cytotoxic effect of this antibody. Altogether, 3D11-mediated protection in the liver is mainly associated with its cytotoxic activity, which leads to the inhibition of sporozoite motility, sinusoidal extravasation, cell invasion, and to the killing inside the liver parenchyma.

Disrupting Cd147-Rap2 Interaction Abrogates Erythrocyte Invasion By Plasmodium Falciparum

Naturally Acquired Antibodies Specific for Plasmodium Falciparum Reticulocyte-Binding Protein Homologue 5 Inhibit Parasite Growth and Predict Protection from Malaria.

A Co-ligand Complex Anchors Plasmodium Falciparum Merozoites to the Erythrocyte Invasion Receptor Band 3

A Human Monoclonal Antibody Prevents Malaria Infection by Targeting a New Site of Vulnerability on the Parasite (vol 24, Pg 408, 2018)

Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection

Late killing of in the liver by an anti-circumsporozoite protein monoclonal antibody

A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites

Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticles

Identification of a specific region of Plasmodium falciparum EBL-1 that binds to host receptor glycophorin B and inhibits merozoite invasion in human red blood cells.

Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45

Plasmodium sporozoite phospholipid scramblase interacts with mammalian carbamoyl-phosphate synthetase 1 to infect hepatocytes

Merozoite Surface Protein 1 Recognition of Host Glycophorin A Mediates Malaria Parasite Invasion of Red Blood Cells.

Receptor-based identification of an inhibitory peptide against blood stage malaria.

Potent LILRB1 D1D2-containing antibodies inhibit RIFIN-mediated immune evasions

Attenuated P. falciparum Parasite Shows Cytokine Variations in Humanized Mice

A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation.

Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions

High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire

Functional and immunological mapping of domains of the reticulocyte binding protein, Plasmodium vivax PvRBP2a

Leveraging Immunofocusing and Virus-like Particle Display to Enhance Antibody Responses to the Malaria Blood-Stage Invasion Complex Antigen PfCyRPA

Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype